Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort

DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury

(2016) Jee Eun Lee et al.   LABORATORY INVESTIGATION

Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes

(2016) Muralikrishna Gangadharan Komala et al.   NEPHROLOGY

Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure

(2016) Daniel F. Arruda-Junior et al.   Frontiers in Physiology

Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker

(2015) Virginia Boccardi et al.   BMC CANCER

Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy

(2015) Eunsoo Jung et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

(2015) Lidia Anguiano et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease

(2015) Masanori Abe et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin

(2015) Muralikrishna Gangadharan Komala et al.   PLoS One

Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4

(2014) Volker Vallon et al.   EXPERIMENTAL PHYSIOLOGY

Cohort profile: Greifswald approach to individualized medicine (GANI_MED)

(2014) Hans J Grabe et al.   Journal of Translational Medicine

Soluble DPP4 originates in part from bone marrow cells and not from the kidney

(2014) Zhendi Wang et al.   PEPTIDES

Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse

(2014) Marta Riera et al.   PLoS One

Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease

(2013) Chengyan Xu et al.   NEPHROLOGY

Con: Should we abandon the use of the MDRD equation in favour of the CKD-EPI equation?

(2013) P. Delanaye et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease

(2013) M. A. Roberts et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Loss of ACE2 Exacerbates Murine Renal Ischemia-Reperfusion Injury

(2013) Fei Fang et al.   PLoS One

N-Terminal Pro-Brain Natriuretic Peptide and Angiotensin-Converting Enzyme-2 Levels and Their Association With Postoperative Cardiac Complications After Emergency Orthopedic Surgery

(2012) Carol P. Chong et al.   AMERICAN JOURNAL OF CARDIOLOGY

Renal Sympathetic Denervation Suppresses De Novo Podocyte Injury and Albuminuria in Rats With Aortic Regurgitation

(2012) Kazi Rafiq et al.   CIRCULATION

Enzymatic activity of DPIV and renin–angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD)

(2012) H. Immo Lehmann et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications

(2011) Aino Soro-Paavonen et al.   JOURNAL OF HYPERTENSION

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

(2010) Andrew S. Levey et al.   KIDNEY INTERNATIONAL

Early recognition and prevention of chronic kidney disease

(2010) Matthew T James et al.   LANCET

On the origin of serum CD26 and its altered concentration in cancer patients

(2009) Oscar J. Cordero et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions

(2009) Siegfried Ansorge et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Health-related Quality of Life in CKD Patients: Correlates and Evolution over Time

(2009) S. K. Mujais et al.   Clinical Journal of the American Society of Nephrology

Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative

(2009) Claudio Ronco et al.   EUROPEAN HEART JOURNAL

Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease

(2009) Roland Bechtloff et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNP

(2009) Yong Wang et al.   JOURNAL OF CARDIAC FAILURE

Albuminuria in chronic heart failure: prevalence and prognostic importance

(2009) Colette E Jackson et al.   LANCET

Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats

(2008) Yasushi Kirino et al.   JOURNAL OF ENDOCRINOLOGY

The Aggravating Mechanisms of Aldosterone on Kidney Fibrosis

(2008) G. Remuzzi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

(2008) Heather N. Reich et al.   KIDNEY INTERNATIONAL

DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis

(2007) Dirk Reinhold   Frontiers in Bioscience-Landmark